Ribosomal RNA maturation: Processes precursor rRNA into 16S and 23S rRNAs, though not strictly essential (alternative ribonucleases compensate in rnc mutants) .
Gene expression regulation:
Modulates ~12% of E. coli mRNAs, with 9% upregulated and 3% downregulated in rnc mutants .
Fitness studies show a bimodal distribution of mutational effects: most mutations are neutral or deleterious, underscoring its optimized activity .
Cleaves a stem-loop in its own 5′ UTR, reducing mRNA stability and limiting protein levels by ~5-fold .
Titrated by rRNA under high-growth conditions, linking enzyme activity to cellular metabolic states .
Phosphorylation: Bacteriophage T7 kinase enhances activity 4-fold during infection to promote viral transcript processing .
Growth-phase dependence: Activity declines in stationary phase, though regulatory mechanisms remain unclear .
Antiviral systems: Exploited in CRISPR-Cas9 adaptations for guide RNA processing .
Gene expression tuning: Used to engineer synthetic circuits by modulating mRNA stability .
Antimicrobial targets: rnc deletion attenuates pathogens like Salmonella, suggesting therapeutic potential .
Structural dynamics: How do post-translational modifications alter RNase III substrate specificity?
Host-pathogen interplay: Can RNase III inhibitors mitigate bacterial virulence without harming host RNA metabolism?
Synthetic biology: Can engineered RNase III variants achieve orthogonal RNA processing in heterologous systems?
KEGG: ect:ECIAI39_2772